Pub Date : 2024-08-30DOI: 10.1016/j.jiph.2024.102537
Grazia Pavia , Francesca Licata , Nadia Marascio , Aida Giancotti , Maria Teresa Tassone , Chiara Costa , Giuseppe Guido Maria Scarlata , Licia Elvira Prestagiacomo , Simona Gigliotti , Enrico Maria Trecarichi , Carlo Torti , Aida Bianco , Angela Quirino , Giovanni Matera
Background
Serodiagnosis of TORCH infections should be performed in pre-pregnancy and reproductive-age women to prevent vertical transmission. Herein, we conducted a 5-year cross-sectional retrospective study in childbearing age women to provide prevalence data. Also, stratifying the cohort into three age groups, we identified those most susceptible to acute TORCH infections.
Methods
Between 2019 and 2023, serum samples from 2286 childbearing age women attending the “R. Dulbecco” University Hospital of Catanzaro were collected. Screening for TORCH pathogens, such as: Toxoplasma gondii (TOX), Cytomegalovirus (CMV), Rubella Virus (RUB), Parvovirus B19 (ParvoB19), Herpes Simplex Virus types 1 and 2 (HSV1, HSV2) and Treponema pallidum was carried out using serological tests. Chemiluminescent immunoassay was performed to detect TOX, CMV and ParvoB19 Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies, while Enzyme Linked Fluorescent Assay was performed to detect RUB IgM and IgG antibodies and CMV and TOX IgG Avidity. Enzyme Linked Immunosorbent Assay was performed to detect HSV1 IgG, HSV2 IgG, HSV1/2 IgM, T. pallidum total antibodies and RUB IgG Avidity. Binomial logistic regression models were developed to compare seroprevalence rates among different age groups.
Results
The highest immunological protection was observed for RUB infection (87 %), probably associated with vaccination practice, followed by HSV1 and CMV (82 % and 63 %). The 16–25 year age group results as the most susceptible to acute infections as demonstrated by odds of CMV IgM positivity (primary infection) which decreased with age.
Conclusions
The TORCH serological screening program should be implemented in women before pregnancy to formulate strategies for serological screening of childbearing age women and guiding clinicians in making decisions.
{"title":"Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: A 5-year cross-sectional retrospective study and a literature review","authors":"Grazia Pavia , Francesca Licata , Nadia Marascio , Aida Giancotti , Maria Teresa Tassone , Chiara Costa , Giuseppe Guido Maria Scarlata , Licia Elvira Prestagiacomo , Simona Gigliotti , Enrico Maria Trecarichi , Carlo Torti , Aida Bianco , Angela Quirino , Giovanni Matera","doi":"10.1016/j.jiph.2024.102537","DOIUrl":"10.1016/j.jiph.2024.102537","url":null,"abstract":"<div><h3>Background</h3><p>Serodiagnosis of TORCH infections should be performed in pre-pregnancy and reproductive-age women to prevent vertical transmission<em>.</em> Herein, we conducted a 5-year cross-sectional retrospective study in childbearing age women to provide prevalence data. Also, stratifying the cohort into three age groups, we identified those most susceptible to acute TORCH infections.</p></div><div><h3>Methods</h3><p>Between 2019 and 2023, serum samples from 2286 childbearing age women attending the “R. Dulbecco” University Hospital of Catanzaro were collected. Screening for TORCH pathogens, such as: <em>Toxoplasma gondii</em> (TOX), Cytomegalovirus (CMV), Rubella Virus (RUB), Parvovirus B19 (ParvoB19), Herpes Simplex Virus types 1 and 2 (HSV1, HSV2) and <em>Treponema pallidum</em> was carried out using serological tests. Chemiluminescent immunoassay was performed to detect TOX, CMV and ParvoB19 Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies, while Enzyme Linked Fluorescent Assay was performed to detect RUB IgM and IgG antibodies and CMV and TOX IgG Avidity. Enzyme Linked Immunosorbent Assay was performed to detect HSV1 IgG, HSV2 IgG, HSV1/2 IgM, <em>T. pallidum</em> total antibodies and RUB IgG Avidity. Binomial logistic regression models were developed to compare seroprevalence rates among different age groups.</p></div><div><h3>Results</h3><p>The highest immunological protection was observed for RUB infection (87 %), probably associated with vaccination practice, followed by HSV1 and CMV (82 % and 63 %). The 16–25 year age group results as the most susceptible to acute infections as demonstrated by odds of CMV IgM positivity (primary infection) which decreased with age.</p></div><div><h3>Conclusions</h3><p>The TORCH serological screening program should be implemented in women before pregnancy to formulate strategies for serological screening of childbearing age women and guiding clinicians in making decisions.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102537"},"PeriodicalIF":4.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002715/pdfft?md5=489d28ffc8036417db733e29d8ffd015&pid=1-s2.0-S1876034124002715-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142161630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-30DOI: 10.1016/j.jiph.2024.102536
Mina Rezghi Rami , Maryam Meskini , Behrouz Ebadi Sharafabad
The advancement of safe, eco-friendly, and cost-efficient techniques for nanoparticle production is a crucial objective in nanotechnology. Among the various sustainable methods, the biological synthesis of nanoparticles utilizing fungi, bacteria, yeasts, and plants stands out. Fungi, in particular, are well suited for this task because of their capacity to secrete numerous enzymes and streamline subsequent processes. Using fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. The utilization of fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. Fungi have long been acknowledged as adept natural engineers capable of creating a wide array of nanoparticles with distinct properties and applications. This article provides an overview of fungus-mediated nanoparticle development, shedding light on the underlying mechanisms of their synthesis and the factors influencing their characteristics. Furthermore, the potential of fungus-mediated nanoparticles in the industrial domain has been explored. These findings emphasize the importance of different fungal species in nanoparticle synthesis, as well as the biocompatibility and environmental friendliness of fungus-mediated nanoparticles. By underscoring the essential role of fungi in connecting natural knowledge with innovative industrial applications, recent progress in enhancing nanoparticle production and optimizing synthesis conditions through fungi has been examined to underscore the feasibility of extensive industrial nanoparticle utilization via fungi.
{"title":"Fungal-mediated nanoparticles for industrial applications: synthesis and mechanism of action","authors":"Mina Rezghi Rami , Maryam Meskini , Behrouz Ebadi Sharafabad","doi":"10.1016/j.jiph.2024.102536","DOIUrl":"10.1016/j.jiph.2024.102536","url":null,"abstract":"<div><p>The advancement of safe, eco-friendly, and cost-efficient techniques for nanoparticle production is a crucial objective in nanotechnology. Among the various sustainable methods, the biological synthesis of nanoparticles utilizing fungi, bacteria, yeasts, and plants stands out. Fungi, in particular, are well suited for this task because of their capacity to secrete numerous enzymes and streamline subsequent processes. Using fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. The utilization of fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. Fungi have long been acknowledged as adept natural engineers capable of creating a wide array of nanoparticles with distinct properties and applications. This article provides an overview of fungus-mediated nanoparticle development, shedding light on the underlying mechanisms of their synthesis and the factors influencing their characteristics. Furthermore, the potential of fungus-mediated nanoparticles in the industrial domain has been explored. These findings emphasize the importance of different fungal species in nanoparticle synthesis, as well as the biocompatibility and environmental friendliness of fungus-mediated nanoparticles. By underscoring the essential role of fungi in connecting natural knowledge with innovative industrial applications, recent progress in enhancing nanoparticle production and optimizing synthesis conditions through fungi has been examined to underscore the feasibility of extensive industrial nanoparticle utilization via fungi.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102536"},"PeriodicalIF":4.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002703/pdfft?md5=d4f325456973acbf9e35c2ba6c294961&pid=1-s2.0-S1876034124002703-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142172943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-30DOI: 10.1016/j.jiph.2024.102535
Yara Khachab, Said El Shamieh, Elie Salem Sokhn
Background
The gut microbiome is made up of a diverse range of bacteria, especially gram-negative bacteria, and is crucial for human health and illness. There is a great deal of interest in the dynamic interactions between gram-negative bacteria and their host environment, especially considering antibiotic resistance. This work aims to isolate gram-negative bacteria that exist in the gut, identify their species, and use resistance-associated gene analysis to define their resistance mechanisms.
Methods
Samples were collected from all patients who had a stool culture at a tertiary care center in Lebanon. Each type of bacteria that was identified from the stool samples was subjected to critical evaluations, and all discovered strains underwent antimicrobial susceptibility testing. Polymerase chain reaction was used to profile the genes for Carbapenem-resistant Enterobacteriaceae (CRE), Extended-spectrum beta-lactamase (ESBL), and that of Pseudomonas aeruginosa strains.
Results
Escherichia coli, Klebsiella species, and Pseudomonas aeruginosa turned out to be the predominant microbiota members. Escherichia coli strains had a high frequency of extended-spectrum beta-lactamase genes, with the most discovered gene being bla CTX-M. Additionally, a considerable percentage of isolates had carbapenemase-resistant Enterobacteriaceae genes, suggesting the rise of multidrug-resistant strains. Multidrug resistance genes, such as bla mexR, bla mexB, and bla mexA, were found in strains of Pseudomonas aeruginosa, highlighting the possible difficulties in treating infections brought on by these bacteria.
Conclusion
The findings highlight the critical importance of effective surveillance and response measures to maintain the effectiveness of antibiotics considering the introduction of multidrug resistance genes in Pseudomonas aeruginosa and ESBL and CRE genes in Escherichia coli.
背景肠道微生物组由多种细菌组成,尤其是革兰氏阴性菌,对人类健康和疾病至关重要。人们对革兰氏阴性细菌与其宿主环境之间的动态相互作用非常感兴趣,特别是考虑到抗生素的耐药性。这项研究旨在分离存在于肠道中的革兰氏阴性细菌,确定其种类,并利用耐药性相关基因分析确定其耐药性机制。对从粪便样本中鉴定出的每种细菌都进行了严格的评估,并对所有发现的菌株进行了抗菌药敏感性测试。聚合酶链反应用于分析耐碳青霉烯类肠杆菌科细菌(CRE)、广谱β-内酰胺酶(ESBL)和铜绿假单胞菌菌株的基因。大肠埃希菌菌株含有高频率的广谱β-内酰胺酶基因,其中发现最多的基因是 bla CTX-M。此外,相当大比例的分离菌株带有耐碳青霉烯酶的肠杆菌科细菌基因,这表明耐多药菌株正在增加。在铜绿假单胞菌菌株中发现了 bla mexR、bla mexB 和 bla mexA 等耐多药基因,凸显了治疗由这些细菌引起的感染可能存在的困难。
{"title":"Gram-negative bacterial colonization in the gut: Isolation, characterization, and identification of resistance mechanisms","authors":"Yara Khachab, Said El Shamieh, Elie Salem Sokhn","doi":"10.1016/j.jiph.2024.102535","DOIUrl":"10.1016/j.jiph.2024.102535","url":null,"abstract":"<div><h3>Background</h3><p>The gut microbiome is made up of a diverse range of bacteria, especially gram-negative bacteria, and is crucial for human health and illness. There is a great deal of interest in the dynamic interactions between gram-negative bacteria and their host environment, especially considering antibiotic resistance. This work aims to isolate gram-negative bacteria that exist in the gut, identify their species, and use resistance-associated gene analysis to define their resistance mechanisms.</p></div><div><h3>Methods</h3><p>Samples were collected from all patients who had a stool culture at a tertiary care center in Lebanon. Each type of bacteria that was identified from the stool samples was subjected to critical evaluations, and all discovered strains underwent antimicrobial susceptibility testing. Polymerase chain reaction was used to profile the genes for Carbapenem-resistant <em>Enterobacteriaceae</em> (CRE), Extended-spectrum beta-lactamase (ESBL), and that of <em>Pseudomonas aeruginosa</em> strains.</p></div><div><h3>Results</h3><p><em>Escherichia coli</em>, <em>Klebsiella</em> species, and <em>Pseudomonas aeruginosa</em> turned out to be the predominant microbiota members. <em>Escherichia coli</em> strains had a high frequency of extended-spectrum beta-lactamase genes, with the most discovered gene being <em>bla</em> CTX-M. Additionally, a considerable percentage of isolates had carbapenemase-resistant <em>Enterobacteriaceae</em> genes, suggesting the rise of multidrug-resistant strains. Multidrug resistance genes, such as <em>bla</em> mexR, <em>bla</em> mexB, and <em>bla</em> mexA, were found in strains of <em>Pseudomonas aeruginosa</em>, highlighting the possible difficulties in treating infections brought on by these bacteria.</p></div><div><h3>Conclusion</h3><p>The findings highlight the critical importance of effective surveillance and response measures to maintain the effectiveness of antibiotics considering the introduction of multidrug resistance genes in <em>Pseudomonas aeruginosa</em> and ESBL and CRE genes in <em>Escherichia coli</em>.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102535"},"PeriodicalIF":4.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002697/pdfft?md5=4c3fb3a611e49e16488e951b01af72b4&pid=1-s2.0-S1876034124002697-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142094964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The COVID-19 pandemic has caused 14.83 million deaths globally. This systematic review and meta-analysis aimed to provide a pooled estimate of the overall mortality and morbidity of critically ill COVID-19 patients.
Method
Four electronic databases, Medline/PubMed, the Cochrane Library, the WHO COVID-19 database, and the Web of Science, were used to identify relevant studies. Two authors independently screened the studies, evaluated the eligibility criteria and resolved discrepancies through discussion with the third author. The pooled effect size was computed using STATA software version 14. The Cochran Q test and I2 test were utilized to assess heterogeneity across the studies. Additionally, subgroup analysis, sensitivity analysis, and publication bias were evaluated. It is registered in Prospero with Prospero ID CRD42020212146.
Results
A total of 1003 published articles were screened from various databases, and 24 studies involving a total of 142,291 critically ill COVID-19 participants were selected for inclusion in the review. Among the participants, 67 % were male, and the mean age was 63.43 + SD3.33 years. The mortality rate reported in the individual studies ranged from 4.5 % to 69.5 %. The findings from the analysis revealed that the overall pooled mortality rate was 34 % (95 % confidence interval: 31 %−37 %). Additionally, the findings showed that 62 % of critically ill COVID-19 patients required mechanical ventilation, while 68.7 % of these patients had chronic disease comorbidities.
Conclusion
Critically ill COVID-19 patients face a high-risk risk of death, with an estimate of about one in three patients dying from the virus. Notably, a substantial portion of critically ill COVID-19 patients (62 %) require mechanical ventilation; surprisingly, more than two-thirds of patients with COVID-19 have chronic disease comorbidities, highlighting the importance of managing comorbidities in this population.
{"title":"Mortality and morbidity in critically ill COVID-19 patients: A systematic review and meta-analysis","authors":"Gebreamlak Gebremedhn Gebremeskel , Degena Bahrey Tadesse , Teklehaimanot Gereziher Haile","doi":"10.1016/j.jiph.2024.102533","DOIUrl":"10.1016/j.jiph.2024.102533","url":null,"abstract":"<div><h3>Background</h3><p>The COVID-19 pandemic has caused 14.83 million deaths globally. This systematic review and meta-analysis aimed to provide a pooled estimate of the overall mortality and morbidity of critically ill COVID-19 patients.</p></div><div><h3>Method</h3><p>Four electronic databases, Medline/PubMed, the Cochrane Library, the WHO COVID-19 database, and the Web of Science, were used to identify relevant studies. Two authors independently screened the studies, evaluated the eligibility criteria and resolved discrepancies through discussion with the third author. The pooled effect size was computed using STATA software version 14. The Cochran Q test and I<sup>2</sup> test were utilized to assess heterogeneity across the studies. Additionally, subgroup analysis, sensitivity analysis, and publication bias were evaluated. It is registered in Prospero with Prospero ID CRD42020212146.</p></div><div><h3>Results</h3><p>A total of 1003 published articles were screened from various databases, and 24 studies involving a total of 142,291 critically ill COVID-19 participants were selected for inclusion in the review. Among the participants, 67 % were male, and the mean age was 63.43 <u>+</u> SD3.33 years. The mortality rate reported in the individual studies ranged from 4.5 % to 69.5 %. The findings from the analysis revealed that the overall pooled mortality rate was 34 % (95 % confidence interval: 31 %−37 %). Additionally, the findings showed that 62 % of critically ill COVID-19 patients required mechanical ventilation, while 68.7 % of these patients had chronic disease comorbidities.</p></div><div><h3>Conclusion</h3><p>Critically ill COVID-19 patients face a high-risk risk of death, with an estimate of about one in three patients dying from the virus. Notably, a substantial portion of critically ill COVID-19 patients (62 %) require mechanical ventilation; surprisingly, more than two-thirds of patients with COVID-19 have chronic disease comorbidities, highlighting the importance of managing comorbidities in this population.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102533"},"PeriodicalIF":4.7,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002673/pdfft?md5=55d59fdeff1dadc850a906824f526410&pid=1-s2.0-S1876034124002673-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Empyema is a serious infection in pleural space. Finding out seasonal variations of empyema and its pathogens can help in providing preventive measures, and implicating future researches.
Methods
This study is a 10-year observational study in a single center. Patients with empyema thoracis receiving thoracoscopic decortication between January 2012 and December 2021 were included in the study.
Results
There were 1082 empyema patients enrolled in this study. No seasonal variation was noted (spring = 25.7 %, summer =25.5 %, autumn = 24.8 %, winter = 24.0 %). However, we observed seasonal variations in pathogens. Streptococcus species had slightly higher prevalence in winter and spring than summer and autumn (54.3 % vs. 45.7 %) without significant difference (p = 0.251). On the contrary, Staphylococcus species occurred more often in summer and autumn than winter and spring (61.5 % vs. 38.5 %) (p = 0.035). Klebsiella species were more likely found in autumn (34.9 %) (p = 0.050), and Pseudomonas species showed no peak prevalence in any season (p = 0.423). The incidence of Streptococcus species increased over the years.
Conclusions
Although no seasonal variation was found in severe empyema patients requiring surgery, there were seasonal variations for the pathogens in Taiwan. The medical community should focus on Streptococcus species in winter and spring and Staphylococcus species in summer and autumn.
{"title":"Seasonal variations of empyema in Taiwan: A 10-year analysis","authors":"Ya-Fu Cheng , Yi-Ling Chen , Wan-Ling Chuang , Chia-Che Chang , Bing-Yen Wang","doi":"10.1016/j.jiph.2024.102534","DOIUrl":"10.1016/j.jiph.2024.102534","url":null,"abstract":"<div><h3>Background</h3><p>Empyema is a serious infection in pleural space. Finding out seasonal variations of empyema and its pathogens can help in providing preventive measures, and implicating future researches.</p></div><div><h3>Methods</h3><p>This study is a 10-year observational study in a single center. Patients with empyema thoracis receiving thoracoscopic decortication between January 2012 and December 2021 were included in the study.</p></div><div><h3>Results</h3><p>There were 1082 empyema patients enrolled in this study. No seasonal variation was noted (spring = 25.7 %, summer =25.5 %, autumn = 24.8 %, winter = 24.0 %). However, we observed seasonal variations in pathogens. <em>Streptococcus</em> species had slightly higher prevalence in winter and spring than summer and autumn (54.3 % vs. 45.7 %) without significant difference (p = 0.251). On the contrary, <em>Staphylococcus</em> species occurred more often in summer and autumn than winter and spring (61.5 % vs. 38.5 %) (p = 0.035). <em>Klebsiella</em> species were more likely found in autumn (34.9 %) (p = 0.050), and <em>Pseudomonas</em> species showed no peak prevalence in any season (p = 0.423). The incidence of <em>Streptococcus</em> species increased over the years.</p></div><div><h3>Conclusions</h3><p>Although no seasonal variation was found in severe empyema patients requiring surgery, there were seasonal variations for the pathogens in Taiwan. The medical community should focus on <em>Streptococcus</em> species in winter and spring and <em>Staphylococcus</em> species in summer and autumn.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102534"},"PeriodicalIF":4.7,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002685/pdfft?md5=8a192b7d856d59fc791ef33d04b33c8e&pid=1-s2.0-S1876034124002685-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142095071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-28DOI: 10.1016/j.jiph.2024.102525
Ibrahim Mahmoud , Mithaq Mohammed A Al Eid , Meera Ahmed Mohamed , Ahmad Jehad Aladwani , Nagwa El Mustafa El Amin
Background
Human papillomavirus (HPV) vaccination and Pap tests are recognized as effective preventive measures to reduce the incidence of HPV-related diseases among young adults. The objective of this study was to assess HPV vaccination and Pap test uptake, awareness, and barriers among young adults in the Gulf Cooperation Council (GCC) countries, including Bahrain, Kuwait, Oman, Qatar, the Kingdom of Saudi Arabia (KSA), and the United Arab Emirates (UAE).
Methods
A comparative cross-sectional study was conducted from January to April 2024, involving 831 young adults aged 18–39 residing in GCC countries. The main outcome measures were HPV vaccination and Pap test uptake rates, awareness of the HPV vaccine and Pap testing, and barriers to vaccination. Data were collected using online platforms. The Chi-square test and Fisher’s exact test were used for data analysis.
Results
The UAE had the highest vaccination rate at 18.9% (50/264), followed by Qatar at 5.8% (6/104), and KSA at 4.6% (10/216), p < 0.001. Individuals with health insurance had higher vaccination rates than those without (11% vs. 5.4%, p = 0.006). Awareness of the HPV vaccine was highest in the UAE (49.6%) and KSA (58.8%), while awareness of Pap smear testing among females was similarly high in these countries (62.4% and 65.9%, respectively). However, actual Pap smear testing rates were highest in Bahrain (15.9%) and Qatar (13.4%). The main barriers to vaccination cited by participants were lack of knowledge (53.6%) and the absence of medical recommendations (13.2%).
Conclusion
The study's findings suggest the need of targeted educational campaigns to increase HPV vaccine uptake among both genders and Pap test participation among females. Additionally, incorporating HPV screening and vaccination into routine national programs in GCC countries and emphasising the crucial role of healthcare providers in influencing vaccination decisions are recommended strategies.
{"title":"Human papillomavirus vaccination and Pap test uptake, awareness, and barriers among young adults in Gulf Cooperation Council countries: A comparative cross-sectional survey","authors":"Ibrahim Mahmoud , Mithaq Mohammed A Al Eid , Meera Ahmed Mohamed , Ahmad Jehad Aladwani , Nagwa El Mustafa El Amin","doi":"10.1016/j.jiph.2024.102525","DOIUrl":"10.1016/j.jiph.2024.102525","url":null,"abstract":"<div><h3>Background</h3><p>Human papillomavirus (HPV) vaccination and Pap tests are recognized as effective preventive measures to reduce the incidence of HPV-related diseases among young adults. The objective of this study was to assess HPV vaccination and Pap test uptake, awareness, and barriers among young adults in the Gulf Cooperation Council (GCC) countries, including Bahrain, Kuwait, Oman, Qatar, the Kingdom of Saudi Arabia (KSA), and the United Arab Emirates (UAE).</p></div><div><h3>Methods</h3><p>A comparative cross-sectional study was conducted from January to April 2024, involving 831 young adults aged 18–39 residing in GCC countries. The main outcome measures were HPV vaccination and Pap test uptake rates, awareness of the HPV vaccine and Pap testing, and barriers to vaccination. Data were collected using online platforms. The Chi-square test and Fisher’s exact test were used for data analysis.</p></div><div><h3>Results</h3><p>The UAE had the highest vaccination rate at 18.9% (50/264), followed by Qatar at 5.8% (6/104), and KSA at 4.6% (10/216), p < 0.001. Individuals with health insurance had higher vaccination rates than those without (11% vs. 5.4%, p = 0.006). Awareness of the HPV vaccine was highest in the UAE (49.6%) and KSA (58.8%), while awareness of Pap smear testing among females was similarly high in these countries (62.4% and 65.9%, respectively). However, actual Pap smear testing rates were highest in Bahrain (15.9%) and Qatar (13.4%). The main barriers to vaccination cited by participants were lack of knowledge (53.6%) and the absence of medical recommendations (13.2%).</p></div><div><h3>Conclusion</h3><p>The study's findings suggest the need of targeted educational campaigns to increase HPV vaccine uptake among both genders and Pap test participation among females. Additionally, incorporating HPV screening and vaccination into routine national programs in GCC countries and emphasising the crucial role of healthcare providers in influencing vaccination decisions are recommended strategies<strong>.</strong></p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102525"},"PeriodicalIF":4.7,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002594/pdfft?md5=b73088d3c00a0768732a24e8a9721d5f&pid=1-s2.0-S1876034124002594-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-27DOI: 10.1016/j.jiph.2024.102524
Oscar Brochado-Kith , Marta Rava , Juan Berenguer , Juan González-García , David Rojo , Cristina Díez , Victor Hontañon , Ana Virseda-Berdices , Luis Ibañez-Samaniego , Elba Llop-Herrera , Antonio Olveira , Leire Pérez-Latorre , Coral Barbas , Amanda Fernández-Rodríguez , Salvador Resino , María Angeles Jiménez-Sousa , the Escorial Study Group
Background
Altered bacterial translocation is associated with changes in hepatic function and the progression from compensated to decompensated cirrhosis. Child-Turcotte-Pugh (CTP) score is an essential indicator of liver severity. Thus, we aimed to study differences in the blood microbiome together with metabolome profile between HCV-infected patients with CTP class B (CTP-B, significant functional compromise) and patients with CTP class A (CTP-A, well-compensated cirrhosis).
Methods
We conducted a cross-sectional study in patients with advanced HCV-related cirrhosis (n = 88) stratified by CTP-B and CTP-A. Bacterial 16S rRNA sequencing was sequenced by MiSeq Illumina technology and non-targeted metabolomics was performed by GC-MS and LC-MS ESI+ and ESI- to complement the analysis.
Results
Patients with CTP-B had lower levels of richness (Chao1), and alpha diversity (Shannon and Simpson indexes) at phylum level than patients with CTP-A. Likewise, we observed significant differences in beta diversity between groups at phylum, class, and order levels, showing lower diversity in patients with CTP-B. Higher relative abundance of Proteobacteria (p = 0.012), Alphaproteobacteria (p = 0.005), Sphingomonadales (p = 0.012) and Sphingomonadaceae (p = 0.016) were significantly associated with CTP-B. The phylum Proteobacteria was positively correlated with ethanolamine and oleic acid (p = 0.005 and p = 0.004, respectively) and negatively with p-cresol (p = 0.006). In addition, the order Sphingomonadales and the family Sphingomonadaceae was also negatively correlated with p-cresol (p = 0.001 and p = 0.001).
Conclusions
Blood microbial diversity was significantly decreased in patients with CTP-B, who presented an enrichment of Proteobacteria, Alphaproteobacteria, Sphingomonadales and Sphingomonadaceae compared to patients with CTP-A.
{"title":"Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis","authors":"Oscar Brochado-Kith , Marta Rava , Juan Berenguer , Juan González-García , David Rojo , Cristina Díez , Victor Hontañon , Ana Virseda-Berdices , Luis Ibañez-Samaniego , Elba Llop-Herrera , Antonio Olveira , Leire Pérez-Latorre , Coral Barbas , Amanda Fernández-Rodríguez , Salvador Resino , María Angeles Jiménez-Sousa , the Escorial Study Group","doi":"10.1016/j.jiph.2024.102524","DOIUrl":"10.1016/j.jiph.2024.102524","url":null,"abstract":"<div><h3>Background</h3><p>Altered bacterial translocation is associated with changes in hepatic function and the progression from compensated to decompensated cirrhosis. Child-Turcotte-Pugh (CTP) score is an essential indicator of liver severity. Thus, we aimed to study differences in the blood microbiome together with metabolome profile between HCV-infected patients with CTP class B (CTP-B, significant functional compromise) and patients with CTP class A (CTP-A, well-compensated cirrhosis).</p></div><div><h3>Methods</h3><p>We conducted a cross-sectional study in patients with advanced HCV-related cirrhosis (n = 88) stratified by CTP-B and CTP-A. Bacterial 16S rRNA sequencing was sequenced by MiSeq Illumina technology and non-targeted metabolomics was performed by GC-MS and LC-MS ESI+ and ESI- to complement the analysis.</p></div><div><h3>Results</h3><p>Patients with CTP-B had lower levels of richness (Chao1), and alpha diversity (Shannon and Simpson indexes) at phylum level than patients with CTP-A. Likewise, we observed significant differences in beta diversity between groups at phylum, class, and order levels, showing lower diversity in patients with CTP-B. Higher relative abundance of Proteobacteria (p = 0.012), Alphaproteobacteria (p = 0.005), Sphingomonadales (p = 0.012) and <em>Sphingomonadaceae</em> (p = 0.016) were significantly associated with CTP-B. The phylum Proteobacteria was positively correlated with ethanolamine and oleic acid (p = 0.005 and p = 0.004, respectively) and negatively with p-cresol (p = 0.006). In addition, the order Sphingomonadales and the family <em>Sphingomonadaceae</em> was also negatively correlated with p-cresol (p = 0.001 and p = 0.001).</p></div><div><h3>Conclusions</h3><p>Blood microbial diversity was significantly decreased in patients with CTP-B, who presented an enrichment of Proteobacteria, Alphaproteobacteria, Sphingomonadales and <em>Sphingomonadaceae</em> compared to patients with CTP-A.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102524"},"PeriodicalIF":4.7,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002582/pdfft?md5=f651de7eb8cb53762cbda610f149d1d5&pid=1-s2.0-S1876034124002582-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report a case of persistent COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.
{"title":"Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report","authors":"Hassan Almarhabi , Aisha Alharbi , Mai Alalawi , Mohamed Firoze Ahamed , Ihab El-Hemaidi , Nader Damfu","doi":"10.1016/j.jiph.2024.102526","DOIUrl":"10.1016/j.jiph.2024.102526","url":null,"abstract":"<div><p>Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report a case of persistent COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102526"},"PeriodicalIF":4.7,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002600/pdfft?md5=8d0f1d131b44d5a68a71b6bfefdd8049&pid=1-s2.0-S1876034124002600-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142122516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-22DOI: 10.1016/j.jiph.2024.102523
Nahawand A. EL-Deeb , Shaherah Yousef Andargeery , Hanaa A. Nofal , Dina S. Elrafey , Ebthall Mohamed , Nevin F. Ibrahim , Hossam Tharwat Ali , Ayman M.E.M. Sadek
Background
The emergence of mucormycosis as a life-threatening fungal infection after the coronavirus disease of 2019 (COVID-19) is a major concern and challenge, but there is limited information on the risk factors for mortality in patients.
Methods
We conducted a prospective cohort study from May 2021 to April 2022 to determine the in-hospital outcomes of post-COVID-19 mucormycosis during the intensive care unit (ICU) stay. The sample of the study was collected as consecutive sampling using all accessible patients in the study period. The Statistical Package for Social Sciences (SPSS), version 25 (IBM, Chicago, Illinois, USA) was used for statistical analysis.
Results
Among 150 patients with post-COVID-19 mucormycosis, the majority had a primary sinus infection (86.0 %), while 11.3 % had both sinus and ocular infections, and 2.7 % had sinus and cutaneous infections. Around 21 % (n = 31) of patients deceased after staying in the ICU for a median (range) of 45.0 (10.0–145.0) days. The majority of the patients who deceased had pneumonia patches on computed tomography (CT) (90.3 %) while none of the patients who were discharged had pneumonia patches (p < 0.001). The deceased group had higher rates of pulmonary embolism (93.5 %) compared to the surviving groups (21.8 %). In a multivariate Cox regression analysis, the risk of death was higher in older patients above 60 years old (hazard ratio (95 %CI): 6.7 (1.73–15.81)), increase among patient with history of steroid administration (hazard ratio (95 %CI): 5.70 (1.23–10.91)), who had facial cutaneous infection with mucormycosis (hazard ratio (95 %CI): 8.76 (1.78–25.18)), patients with uncontrolled diabetes (hazard ratio (95 %CI): 10.76 (1.78, 65.18)), and total leukocytic count (TLC>10 ×103 mcL) (hazard ratio (95 %CI): 10.03 (3.29–30.61)).
Conclusions
Identifying high-risk patients especially old diabetic patients with corticosteroid administration and detecting their deterioration quickly is crucial in reducing post-COVID-19 mucormycosis mortality rates, and these factors must be considered when developing treatment and quarantine strategies.
{"title":"Post COVID-19 mucormycosis in critical care settings: A prospective cohort study in a tertiary care center in Egypt","authors":"Nahawand A. EL-Deeb , Shaherah Yousef Andargeery , Hanaa A. Nofal , Dina S. Elrafey , Ebthall Mohamed , Nevin F. Ibrahim , Hossam Tharwat Ali , Ayman M.E.M. Sadek","doi":"10.1016/j.jiph.2024.102523","DOIUrl":"10.1016/j.jiph.2024.102523","url":null,"abstract":"<div><h3>Background</h3><p>The emergence of mucormycosis as a life-threatening fungal infection after the coronavirus disease of 2019 (COVID-19) is a major concern and challenge, but there is limited information on the risk factors for mortality in patients.</p></div><div><h3>Methods</h3><p>We conducted a prospective cohort study from May 2021 to April 2022 to determine the in-hospital outcomes of post-COVID-19 mucormycosis during the intensive care unit (ICU) stay. The sample of the study was collected as consecutive sampling using all accessible patients in the study period. The Statistical Package for Social Sciences (SPSS), version 25 (IBM, Chicago, Illinois, USA) was used for statistical analysis.</p></div><div><h3>Results</h3><p>Among 150 patients with post-COVID-19 mucormycosis, the majority had a primary sinus infection (86.0 %), while 11.3 % had both sinus and ocular infections, and 2.7 % had sinus and cutaneous infections. Around 21 % (n = 31) of patients deceased after staying in the ICU for a median (range) of 45.0 (10.0–145.0) days. The majority of the patients who deceased had pneumonia patches on computed tomography (CT) (90.3 %) while none of the patients who were discharged had pneumonia patches (<em>p</em> < 0.001). The deceased group had higher rates of pulmonary embolism (93.5 %) compared to the surviving groups (21.8 %). In a multivariate Cox regression analysis, the risk of death was higher in older patients above 60 years old (hazard ratio (95 %CI): 6.7 (1.73–15.81)), increase among patient with history of steroid administration (hazard ratio (95 %CI): <strong>5</strong>.70 (1.<strong>2</strong>3–1<strong>0.9</strong>1)), who had facial cutaneous infection with mucormycosis (hazard ratio (95 %CI): 8.76 (1.78–25.18)), patients with uncontrolled diabetes (hazard ratio (95 %CI): 10.76 (1.78, 65.18)), and total leukocytic count (TLC>10 ×103 mcL) (hazard ratio (95 %CI): 10.03 (3.29–30.61)).</p></div><div><h3>Conclusions</h3><p>Identifying high-risk patients especially old diabetic patients with corticosteroid administration and detecting their deterioration quickly is crucial in reducing post-COVID-19 mucormycosis mortality rates, and these factors must be considered when developing treatment and quarantine strategies.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 10","pages":"Article 102523"},"PeriodicalIF":4.7,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002570/pdfft?md5=c287c13c734d565719d6ac74c1e88b52&pid=1-s2.0-S1876034124002570-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142095072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-17DOI: 10.1016/j.jiph.2024.102519
Stefan Poier , Anna Maria Nikodemska-Wołowik
Background
The governments of democracies worldwide are relying on the active cooperation of their populations to combat COVID-19. Simultaneously, beliefs in conspiracy theories surrounding the pandemic have flourished. The present article examines the effects of the big five personality traits and conspiracy beliefs on the intention to get vaccinated against COVID-19 in Germany.
Methods
This correlational, cross-sectional mediation analysis was conducted using data from a nationwide German household panel (N = 1390).
Results
Openness to experience (β = −.082, p = .004) and neuroticism (β = .112, p < .001) showed direct effects on conspiracy beliefs, while conspiracy beliefs had the strongest effect on vaccination intention (β = −.424, p < .001). Indirect positive effects of openness (β = .035, p = .005) and negative effects of neuroticism (β = −.047, p < .001) on the intention to get vaccinated via conspiracy beliefs were identified, with a mediation in the strict sense only for openness. No direct or total effect of the big five on vaccination intention could be found.
Conclusions
The big five personality traits are associated, although indirectly, with the intention to be vaccinated. Compared with similar studies on the effects of the big five on COVID-19-related outcomes, we found slightly higher proportions of explained variance in conspiracy beliefs and significantly higher explained variance in vaccination intention. In order to increase the willingness to be vaccinated, targeted and nationwide uniform information measures should be provided addressing feelings of security, of not being excluded, and the activation of critical reasoning.
{"title":"Germany under the Tinfoil Hat? The associations of the big five personality traits and coronavirus conspiracy beliefs with the intention to get vaccinated","authors":"Stefan Poier , Anna Maria Nikodemska-Wołowik","doi":"10.1016/j.jiph.2024.102519","DOIUrl":"10.1016/j.jiph.2024.102519","url":null,"abstract":"<div><h3>Background</h3><p>The governments of democracies worldwide are relying on the active cooperation of their populations to combat COVID-19. Simultaneously, beliefs in conspiracy theories surrounding the pandemic have flourished. The present article examines the effects of the big five personality traits and conspiracy beliefs on the intention to get vaccinated against COVID-19 in Germany.</p></div><div><h3>Methods</h3><p>This correlational, cross-sectional mediation analysis was conducted using data from a nationwide German household panel (N = 1390).</p></div><div><h3>Results</h3><p>Openness to experience (β = −.082, p = .004) and neuroticism (β = .112, p < .001) showed direct effects on conspiracy beliefs, while conspiracy beliefs had the strongest effect on vaccination intention (β = −.424, p < .001). Indirect positive effects of openness (β = .035, p = .005) and negative effects of neuroticism (β = −.047, p < .001) on the intention to get vaccinated via conspiracy beliefs were identified, with a mediation in the strict sense only for openness. No direct or total effect of the big five on vaccination intention could be found.</p></div><div><h3>Conclusions</h3><p>The big five personality traits are associated, although indirectly, with the intention to be vaccinated. Compared with similar studies on the effects of the big five on COVID-19-related outcomes, we found slightly higher proportions of explained variance in conspiracy beliefs and significantly higher explained variance in vaccination intention. In order to increase the willingness to be vaccinated, targeted and nationwide uniform information measures should be provided addressing feelings of security, of not being excluded, and the activation of critical reasoning.</p></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"17 9","pages":"Article 102519"},"PeriodicalIF":4.7,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1876034124002533/pdfft?md5=1c64ddc9efb248fb57e6a283ad7197af&pid=1-s2.0-S1876034124002533-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}